Approval · Notice of Compliance 5542 · 2004
COSOPT: Notice of Compliance 5542
Issued October 1, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5542
- Date
- October 1, 2004
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new formulation that is preservative-free
- Therapeutic class
- Elevated intraocular pressure therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COSOPT | 02258692 | Marketed |
Medicinal ingredients
- TIMOLOL MALEATE 5 MG per ML
- DORZOLAMIDE HYDROCHLORIDE 20 MG per ML